JNJ/AbbVie's Imbruvica + Venclexta show promising progression-free survival in late-stage blood cancer study
June 14 2021 - 4:26AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024